Nano-Pharmacokinetics and Theranostics
Advancing Cancer Therapy
- Publisher's listprice EUR 175.00
-
72 581 Ft (69 125 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 14 516 Ft off)
- Discounted price 58 065 Ft (55 300 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
72 581 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 30 July 2021
- ISBN 9780323850506
- Binding Paperback
- No. of pages324 pages
- Size 234x190 mm
- Weight 680 g
- Language English
- Illustrations 170 illustrations (20 in full color) 183
Categories
Long description:
Nano-Pharmacokinetics and Theranostics: Advancing Cancer Therapy addresses from a comprehensive and multidisciplinary approach the translational aspects and clinical perspectives of nano-pharmacokinetics using cancer as a model disease. Nano-pharmacokinetics is emerging as an important sub discipline of nanoscience and medical sciences because of the increasing safety issues of nanosystems on living organisms. This book reports the dynamics of nanosystems in living organisms for better understanding of nanotoxicity, pharmacology, biochemistry, physiology and medicine perspectives. It further examines current progress of state-of-the art pharmacokinetics mechanisms, which will be of great help to develop more clinical-oriented nanosystems with a wide safety margin. The book is divided into three sections: the first section focuses on the concept of pharmacokinetics with state-of-the-art Nano-Pharmacokinetics (NPK). The second section looks at the engineering of nanoparticles and pharmacokinetics clinical development. The final section focuses on Nano-Pharmacokinetics and Theranostics, elaborating the basic question of how pharmacokinetics of nanomaterials relate to their end applications such as cancer therapy. Nano-Pharmacokinetics and Theranostics: Advancing Cancer Therapy will be useful to researchers in the field of nanoparticle based targeted drug delivery including pharmaceutical scientists, material scientists, chemists, nanotechnologists, biomedical scientists, and clinicians.
MoreTable of Contents:
Section I: Nano-Pharmacokinetics Current state of the art
1. Introduction
2. Nano-Pharmacokinetics (NPK): Current state of the art
3. Engineered Nanomaterials and Pharmacokinetics
Section II: Nano-Pharmacokinetics Clinical development
4. Nano-Pharmacokinetics: Bio distributionï¿1⁄2and toxicology
5. Biological systems and Nano-Pharmacokinetics
6. Nano-Pharmacokinetics Assessment
Section III: Nano-Pharmacokinetics and cancer
7.ï¿1⁄2Clinical significance of nanomaterials in cancer treatment
8. Nano-Pharmacokinetics and Theranostics: Co relation
9. Nano-Pharmacokinetics key role in cancer theranostics
10. Nano-Pharmacokinetics key role in in vivo imaging Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship
11. Nano-Pharmacokinetics Preclinical to Clinical Translation
12. Current pre-clinical stage of Nano-Pharmacokinetics
13. Advances inï¿1⁄2Clinical translation of Nano-Pharmacokinetics
14. Future Outlook and Conclusion
Amsterdamer Beiträge zur älteren Germanistik, Band 72 (2014)
35 668 HUF
32 815 HUF
